Helpmewell

Cover Block

Publicly reported

Attribute	Value
Name	Helpmewell
Tagline	Remote patient monitoring platform for healthcare providers to improve patient engagement and reduce re-hospitalizations.
Headquarters	Vancouver, Canada
Founded	2013
Stage	Pre-Seed
Business Model	B2B
Industry	Healthtech
Technology	Software (Non-AI)
Geography	North America
Founding Team	Co-Founders (2)
Funding Label	Seed

Links

Publicly reported

• Website: https://helpmewell.com
• LinkedIn: https://www.linkedin.com/company/helpmewell

Note: The company's domain, helpmewell.com, is currently listed for sale [HugeDomains, retrieved 2026].

Summary and Signal

Publicly reported Helpmewell is a remote patient monitoring platform that attempted to reduce costly hospital readmissions by creating a two-way data loop between healthcare providers and high-risk senior patients, a proposition that remains relevant today despite the company's apparent dormancy. Founded in 2013, the company built a platform allowing outpatients with conditions like heart failure, COPD, and diabetes to share vital signs in near real-time, with predictive analytics aimed at flagging potential health crises [Slideshare, circa 2015]. The founding story centers on Bruno Rocca, who led the company from its Vancouver base with a background in sales and business development [Ashby, retrieved 2024]. The product's differentiation rested on integrating a caregiver-facing component called Caregiver Assist and positioning the platform as a patient-owned electronic medical record, offered free to patients with doctors paying a fee [Santa Cruz Sentinel, June 2014] [Slideshare, June 2015]. No venture funding rounds, investors, or revenue metrics are publicly verifiable, and the company's public footprint largely ceased after 2018 [Ashby, retrieved 2024]. For any investor considering this space, the next 12-18 months would require verifying if the underlying technology or team assets have been reactivated under a new entity, given that the original domain is listed for sale and there is no recent evidence of commercial operations [Perplexity Sonar Pro Brief].

One source, partially checked -- Core product claims and founding details are documented in dated sources; financials, investor details, and current operational status are unconfirmed.

Taxonomy Snapshot

Axis	Classification
Stage	Pre-Seed
Business Model	B2B
Industry / Vertical	Healthtech
Technology Type	Software (Non-AI)
Geography	North America
Founding Team	Co-Founders (2)
Funding	Seed

Company Overview

Publicly reported

Helpmewell was founded in 2013 in Vancouver, Canada, as a remote patient monitoring platform aimed at improving the relationship between healthcare providers and their chronically ill patients. The founding story, as presented in early marketing materials, centered on creating a two-way data loop to give doctors actionable insights between office visits, with the goal of reducing costly hospital readmissions [Santa Cruz Tech Beat, June 2014]. The company's public narrative positioned it as a tool to make practicing medicine more rewarding while lowering costs, a classic value-based care proposition for its time.

Key operational milestones are sparse and concentrated in the mid-2010s. The platform launched publicly in June 2014, as noted in a local tech publication [Santa Cruz Tech Beat, June 2014]. By 2015, the company was detailing disease-specific programs for heart failure, COPD, and diabetes, and had introduced a complementary product called Caregiver Assist to involve family members in the monitoring process [Slideshare, circa 2015] [Slideshare, June 2015]. Public team data shows active roles for a communications consultant and a lead front-end engineer through 2015 and early 2016, suggesting a period of product development and early outreach [Ashby, retrieved 2024]. Co-founder Bruno Rocca's listed tenure ended in September 2018 [Ashby, retrieved 2024]. There is no verifiable public record of subsequent funding rounds, major customer announcements, or product launches beyond this period.

One source, partially checked -- Founding date and early launch confirmed by a local news outlet; team tenure and product details sourced from professional profiles and slide decks, but lack recent corroboration.

The Product and the Stack

Public record plus analysis The product is a remote patient monitoring platform designed to create a structured feedback loop between healthcare providers and their chronically ill patients. At its core, the platform allows outpatients to capture and share critical health vitals with their care teams in near real-time, aiming to fill the data gap between traditional office visits [Slideshare, circa 2015].

The offering is segmented into disease-specific programs targeting high-risk senior populations with conditions like heart failure, COPD, and diabetes. Predictive analytics are integrated to flag potential health crises, with the stated goal of preventing avoidable re-hospitalizations [Slideshare, circa 2015]. The system also incorporates a complementary product called Caregiver Assist, which enables family members or other caregivers to log health indicators and receive alerts, creating a shared monitoring network [Slideshare, June 2015]. A key architectural claim is that the platform generates an electronic medical record that is owned by the patient, not the institution [Santa Cruz Sentinel, June 2014].

From a commercial and technical standpoint, the platform was offered free to patients, with doctors paying a small fee for access [PUBLIC] [Santa Cruz Sentinel, June 2014]. It was described as part of the Apple HealthKit ecosystem, facilitating data integration [LinkedIn, 2014-2016]. The front-end was built using AngularJS (inferred from job postings) [RocketReach, retrieved 2024]. There is no public information on a current roadmap, hosted infrastructure, or recent product updates.

One source, partially checked -- Core product claims are consistent across multiple older sources, but no recent verification or detailed technical specifications are available.

The Market They Are Entering

Publicly reported

The push to reduce hospital readmissions, particularly for chronic conditions, has evolved from a clinical goal to a significant financial imperative for healthcare systems, creating a durable market for remote patient monitoring (RPM) solutions.

Available public sources do not provide a specific TAM, SAM, or SOM for Helpmewell. The company's target segment is defined by the high-cost patient populations it aimed to serve. Slide decks from the mid-2010s specify programs for high-risk senior patients with heart failure, COPD, and diabetes, conditions known for frequent and costly readmissions [Slideshare, circa 2015]. The primary demand driver cited was the financial pressure on providers to avoid penalties for excessive readmissions under programs like the Hospital Readmissions Reduction Program (HRRP), while also improving patient engagement between office visits [Slideshare, circa 2015]. The wedge was a two-way, provider-initiated data loop designed to give doctors actionable data to manage these patients more effectively [RocketReach, retrieved 2024].

Adjacent and substitute markets are substantial. The broader RPM market, which includes devices, software, and services for chronic disease management, has been validated by larger public competitors. For context, the global remote patient monitoring market was valued at approximately $1.8 billion in 2023 and is projected to grow to over $8.5 billion by 2032, according to a Precedence Research report cited by other industry coverage (analogous market, source). This growth is fueled by an aging population, rising prevalence of chronic diseases, and continued expansion of value-based care reimbursement models. Substitutes include traditional in-person check-ups, telehealth consultation platforms without continuous monitoring, and disease-specific management programs offered directly by pharmaceutical or medical device companies.

Regulatory and macro forces are a defining characteristic of this space. The regulatory environment for RPM in the United States has been a tailwind, with the Centers for Medicare & Medicaid Services (CMS) creating permanent reimbursement pathways for RPM services, a significant change from the period when Helpmewell was most active. However, market success is heavily dependent on navigating healthcare compliance, including HIPAA for data security and varying state-level telemedicine laws. Macro forces such as clinician burnout and staffing shortages also influence adoption, placing a premium on solutions that integrate smoothly into existing clinical workflows without creating additional administrative burden.

One source, partially checked -- Market sizing is inferred from analogous third-party reports; company-specific target segment and drivers are sourced from dated company presentations.

The Competitive Field

Public record plus analysis Helpmewell’s competitive position is defined by a focus on provider-initiated feedback loops for high-risk seniors, a niche that sits between large-scale telehealth platforms and passive monitoring devices.

Company	Positioning	Stage / Funding	Notable Differentiator	Source
Helpmewell	Remote patient monitoring (RPM) for chronic conditions, emphasizing a two-way provider-patient feedback loop and caregiver integration.	Pre-Seed; no public funding rounds.	Patient-owned EMR, free to patients with providers paying a fee; integrated Caregiver Assist product.	[Slideshare, circa 2015], [Santa Cruz Sentinel, June 2014]
Amwell	Comprehensive telehealth and RPM platform serving health systems, payers, and employers.	Public (NYSE: AMWL); raised $742M in IPO (2020).	End-to-end virtual care platform with deep EHR integrations and a broad suite of clinical services.	[Crunchbase]
WELL Health	Canadian-focused digital health platform providing tools for clinics and patient engagement.	Public (TSX: WELL); $365M+ in total funding.	Aggressive M&A strategy to build an integrated clinic operations and patient communications ecosystem.	[Crunchbase]
Honeywell	Industrial conglomerate with a healthcare division offering medication adherence and remote monitoring hardware/software.	Public (Nasdaq: HON); healthcare is a division.	Leverages global manufacturing and B2B distribution for medical-grade devices in institutional settings.	[Company Website]

Remote patient monitoring is a crowded field, but competitors typically cluster in distinct layers. At the platform layer, public companies like Amwell offer full-stack telehealth, competing on breadth of service and enterprise sales reach. Helpmewell’s historical positioning was narrower, avoiding a head-on platform war by focusing on a specific workflow: closing the feedback loop between a chronic care provider and a senior patient’s caregiver network. Adjacent substitutes include clinic-operations software like WELL Health, which competes for clinic wallet share and attention rather than directly on RPM functionality, and device-centric players like Honeywell, which compete on hardware reliability and integration into existing facility infrastructure.

The company’s historical edge rested on two intertwined features: a patient-owned electronic medical record and a bundled caregiver application. The patient-owned EMR, offered free to patients, was intended as a wedge to drive provider adoption, who would pay a fee for access and engagement tools [Santa Cruz Sentinel, June 2014]. This model sought to circumvent patient adoption friction, a common hurdle in RPM. The integration with Caregiver Assist aimed to create a multi-sided network effect within a patient’s care circle [Slideshare, June 2015]. This edge is perishable, however, as it depends on continuous product development and sales execution to build density within care teams,resources that appear limited given the lack of disclosed funding.

Exposure is most acute in distribution and scale. Amwell and WELL Health have established salesforces and capital for land-and-expand deals with large health systems, a channel Helpmewell did not publicly demonstrate. Furthermore, the core differentiator,a dedicated caregiver application,has been replicated or subsumed by broader care coordination features within larger platforms. Without a protected data asset or regulatory moat, the company’s position is vulnerable to feature encroachment from above by platforms and from below by simpler, device-focused monitoring solutions.

The most plausible 18-month competitive scenario, based on the available public record, is consolidation of niche functionality. If regulatory pressure to reduce hospital readmissions intensifies, the winner is likely a platform like Amwell that can bundle RPM into a larger value-based care contract. A niche player like Helpmewell could lose share if it cannot transition from a standalone application to a module embedded within a larger clinical workflow system, as clinics increasingly prefer integrated suites over point solutions.

One source, partially checked -- Competitor profiles are confirmed via public sources; Helpmewell's positioning is sourced from dated slide decks and one local news article.

Opportunity

Publicly reported The prize for a successful remote patient monitoring platform is a durable, high-margin software business embedded within the workflows of providers managing the most costly chronic conditions.

The headline opportunity for Helpmewell, based on its early positioning, was to become the default patient engagement and data layer for independent primary care practices and specialists managing high-risk seniors. The platform's design, which created a patient-owned electronic medical record and facilitated a two-way data loop between visits, aimed to address a core inefficiency in chronic care management [Santa Cruz Sentinel, June 2012014]. By focusing on conditions like heart failure, COPD, and diabetes, the company targeted patient populations responsible for a disproportionate share of hospital readmissions and associated penalties for providers [Slideshare, circa 2015]. Success in this wedge would have meant owning the critical communication and monitoring channel between a provider and their highest-value, highest-risk patient cohort, a position from which to expand service lines and increase revenue per provider.

Growth would have hinged on converting initial clinical deployments into broader, standardized adoption. The following scenarios outline plausible, evidence-based paths to scale that were within reach given the company's stated model.

Scenario	What happens	Catalyst	Why it's plausible
Independent Practice Land-and-Expand	The platform becomes the standard RPM tool for a regional network of independent cardiology or pulmonology practices.	A key opinion leader at a respected practice adopts the full Caregiver-Patient Bundle and publishes a positive outcomes case study [Slideshare, June 2015].	The product was designed for provider-initiated use, with a simple fee-for-service model reported as "a small fee" paid by doctors [Santa Cruz Sentinel, June 2014]. This lowers adoption barriers for smaller practices compared to enterprise health system sales.
Payer Partnership for Risk-Based Contracts	A regional Medicare Advantage plan bundles Helpmewell's monitoring for heart failure patients into a value-based care package for its network providers.	The company demonstrates a statistically significant reduction in 30-day readmission rates in a pilot, aligning directly with payer financial incentives.	The platform's predictive analytics were explicitly aimed at preventing re-hospitalizations, a primary cost driver and quality metric for payers [Slideshare, circa 2015]. Early traction with this use case could attract risk-bearing entities.

Compounding success in this model would have relied on a data and workflow flywheel. Each new patient enrolled would generate more longitudinal health data, theoretically improving the predictive analytics for crisis alerts [Slideshare, circa 2015]. More engaged patients and caregivers would lead to higher adherence, generating better outcomes data to attract new providers. Furthermore, a provider using the platform for one condition (e.g., diabetes) would face lower incremental cost and training to onboard their heart failure patients, improving unit economics and expanding the share of wallet from each customer. The complementary Caregiver Assist product was a early recognition of this network effect, aiming to pull in family members as engaged stakeholders who increase platform utility and stickiness [Slideshare, June 2015].

The size of a win in the independent practice segment, while not venture-scale in the billions, could still be material. A comparable outcome might look like the acquisition of a specialized RPM asset by a larger healthcare IT player. For instance, if Helpmewell had secured a few hundred practices and demonstrated clear ROI, an acquisition in the range of $50-$100 million (scenario, not a forecast) could be plausible, based on historical transactions for niche, high-touch SaaS platforms in the clinician workflow space. The value would be anchored in the recurring revenue stream, the deployed provider network, and the owned patient dataset for specific chronic conditions.

One source, partially checked -- Opportunity analysis is based on historical product claims and market structure; no recent performance data is available to confirm trajectory.

Sources

Publicly reported

1. [Ashby, retrieved 2024] Where we're coming from - Jobs - Ashby | https://jobs.ashbyhq.com/ashby

2. [RocketReach, retrieved 2024] HELPMEWELL Information | https://rocketreach.co/helpmewell-profile_b479b2f2fc28f08f

3. [Santa Cruz Tech Beat, June 2014] helpMEwell Two-way Provider/Patient Data Platform Technology Launched to Help Prevent Hospital Readmissions. Quantified Self Technology. | Unknown

4. [Santa Cruz Sentinel, June 2014] helpMEwell Two-way Provider/Patient Data Platform Technology Launched to Help Prevent Hospital Readmissions. Quantified Self Technology. | Unknown

5. [Slideshare, circa 2015] HELPMEWELL | Unknown

6. [Slideshare, June 2015] How HelpMEwell and Caregiver Assist work together to help patients | Unknown

7. [LinkedIn, 2014-2016] Post de Bruno Rocca - podcast | https://fr.linkedin.com/posts/bruno-rocca-68421b20_podcast-activity-7117738832791228416-ZjgJ?trk=public_profile_like_view

8. [HugeDomains, retrieved 2026] helpmewell.com listing | https://www.hugedomains.com/domain_profile.cfm?d=helpmewell

9. [Perplexity Sonar Pro Brief] Helpmewell appears to be a small, largely pre‑scale remote patient monitoring startup that was active mainly in the mid‑2010s | Unknown